Marion McCourt, EVP Commercial at REGENERON PHARMACEUTICALS, INC. (REGN), sold 548 shares at $873.91 ($479K) on 2024-01-02, disclosed to the SEC on 2024-01-04.
Scheduled sale ($479k) by EVP Commercial under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $873.91 | 274 | $239K | 50.0% |
| 2 | $873.91 | 274 | $239K | 50.0% |
| Total | $873.91 avg | 548 | $479K | 100% |
| Filing → |
| REGN | SELL | 2024-11-05 | $845K | — | Filing → |
| REGN | SELL | 2024-10-03 | $1.1M | — | Filing → |
| REGN | SELL | 2024-09-05 | $1.2M | — | Filing → |